Health Condition 1: I208- Other forms of angina pectoris
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Abbott Healthcare Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed with Chronic stable angina 2. Patients who are newly initiated on medical management for chronic stable angina. 3. Patients of chronic stable angina with or without Type 2 Diabetes Mellitus as a comorbidity.
Exclusion criteria
Exclusion criteria: 1. Investigators judgement about their disease status of Chronic Coronary Syndrome. 2. Hospitalizations for acute coronary syndrome i.e. myocardial infarction or unstable angina within the past 3 months. 3. Uncontrolled hypertension, defined as systolic blood pressure greater than equal to 180 mmHg or diastolic blood pressure greater than equal to 100 mmHg, despite ongoing antihypertensive therapy 4. New York Heart Association Class III or IV heart failure 5. Current pregnant or breastfeeding 6. Planned coronary artery revascularization surgical or percutaneous within the next 3 months 7. Severe hepatic or renal impairment, or any other significant chronic medical condition requiring continuous treatment. 8. Use of antianginal therapy within the past 3 months for stable angina.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1 Duration of chronic stable angina 2 Demographic variables including a. Age, Sex distribution or Socioeconomic status, b. Presence of comorbid conditions such as hypertension, hypercholesterolemia and DM and CV risk factors including alcohol use and tobacco smoking 3 Patients receiving antianginal medications and reporting change in antianginal treatment 4 Proportion of patients requiring addon therapyTimepoint: 1 or 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change from baseline in Canadian Cardiovascular Society angina class at 3 months. 2. Change in number of short acting nitrates consumed per week from baseline to 3 months. 3. Change in the mean number of weekly angina attacks 4. Effectiveness of different anti anginal regimens 1 or more molecules based on the secondary endpointsTimepoint: Baseline 1 month or 3 months | — |
Countries
India
Contacts
Public ContactDr Somesh Bolegave
Abbott Healthcare Private Limited
Outcome results
None listed